- Date:
- October 2002 - 2007
International HapMap Project
-
What is the International HapMap Project?
The International HapMap Project was a global collaboration that aimed to identify genetic variations contributing to human disease by creating a haplotype map of the human genome. A haplotype is a set of alleles that are located close together on a single chromosome and tend to be inherited together.
The project, which began in October 2002, involved scientists from Canada, China, Japan, Nigeria, the United Kingdom, and the United States. It utilized data from the Human Genome Project and the Database of Single Nucleotide Polymorphisms (dbSNP). Researchers initially focused on identifying one common SNP in every 5,000 DNA bases from four distinct populations, and the project has raised ethical considerations regarding potential stigmatization of ethnic groups found to be at increased risk for certain diseases.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
Why was the HapMap Project started?
The International HapMap Project began in October 2002 as an international collaboration to identify genetic variations that contribute to human disease through the development of a haplotype map of the human genome.
The inefficiency of analyzing each Single Nucleotide Polymorphism (SNP) separately to identify associations with health and disease led researchers to explore haplotypes. The project generated data on SNPs and haplotypes within distinct ethnic populations, raising ethical concerns. Despite this, it improved the understanding of genetic variation within populations and enabled the development of population-based screening technologies that are fundamental for disease prevention. The HapMap database, along with other resources such as the human genome database, has facilitated the identification of various genes associated with disease.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What is a haplotype in genetics?
A haplotype is a cluster of linked alleles, or forms of genes, located closely on a single chromosome, and typically inherited together as a unit.
The International HapMap Project was launched in 2002 to create a haplotype map of the human genome to identify genetic variations that contribute to human diseases. Researchers tagged several single nucleotide polymorphisms (SNPs) in a haplotype region to associate traits, such as the risk of certain cancers or heart disease, with the millions of SNPs in the human genome.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How did scientists collect and use DNA samples in the HapMap Project?
In the International HapMap Project, scientists aimed to identify genetic variations that contribute to human disease by creating a haplotype map of the human genome. Researchers initially tried to identify one common SNP in every 5,000 DNA bases from four distinct populations.
To detect SNPs, they used various genotyping technologies to identify the specific alleles each person carried. In the first two phases, researchers investigated DNA from 270 individuals, including Japanese persons, Americans of European descent, members of the Han Chinese ethnic group, and members of the Yoruba people of Nigeria. Phase I identified roughly one million SNPs, and Phase II produced data on over 3.1 million SNPs. Later, in HapMap 3, data on over 1,000 new samples from 11 populations was published.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How does the HapMap help researchers find genes related to diseases?
The International HapMap Project helps researchers identify genetic variations that contribute to human diseases by creating a haplotype map of the human genome. A haplotype is a set of alleles that are located close together on a single chromosome and are often inherited together.
The inefficiency of analyzing each Single Nucleotide Polymorphism (SNP) separately led researchers to explore haplotypes. Each haplotype region contains multiple SNPs, which may be associated with a specific trait. By tagging only several of the SNPs, researchers can quickly sort through millions of SNPs to find those most relevant to disease. Identifying disease-associated SNPs can provide information on disease risk and facilitate the development of new drugs and diagnostic techniques.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What impact has the HapMap Project had on genetic research and medicine?
The International HapMap Project aimed to identify genetic variations that contribute to human disease by creating a haplotype map of the human genome. By mapping haplotypes, scientists can link genetic variants to specific diseases, enhancing our understanding of disease risk and paving the way for new diagnostic and therapeutic strategies.
The project has raised ethical considerations, such as the potential for stigmatization of ethnic groups found to be at increased risk for certain diseases. However, it has also facilitated the development of population-based screening technologies for disease prevention and has been used to study variations in response to environmental factors, including prescription drugs. The HapMap project, along with the Human Genome Project, has been crucial to the rise of personalized medicine.
3 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
International HapMap Project, an international collaboration aimed at the identification of genetic variations contributing to human disease through the development of a haplotype (haploid genotype) map of the human genome. A haplotype is a set of alleles (differing forms of genes) that occur close together on a single chromosome and tend to be inherited together. By identifying haplotypes and mapping their chromosomal locations, scientists are able to associate genetic variants with specific diseases and disorders.
The International HapMap Project originated in October 2002, supported by private and public funding, with participating scientists located in Canada, China, Japan, Nigeria, the United Kingdom, and the United States. The HapMap effort was an outgrowth of the Human Genome Project (HGP), which was completed in 2003. In addition to making use of the genome sequence data published by the HGP, HapMap researchers utilized the Database of Single Nucleotide Polymorphisms (dbSNP) maintained by the National Center for Biotechnology Information, a branch of the U.S. National Institutes of Health. The dbSNP contains information on millions of genetic variations in single nucleotides in DNA (the four DNA nucleotides are adenine [A], guanine [G], thymine [T], and cytosine [C]). An example of such a variation is the presence at a given polymorphic site on a chromosome of a T in some persons versus an A in others. SNPs occur regularly and frequently throughout the human genome, with approximately 1 in every 300 bases, or an estimated total of 10 million within the 3 billion nucleotides of the full-length genome.
The inefficiency of analyzing each SNP separately to identify associations with health and disease led researchers to explore haplotypes. Each haplotype region contains multiple SNPs, which may be associated with a specific trait, such as increased risk for heart disease or certain cancers. Because the polymorphisms in a single haplotype region occur close together, only several of the SNPs need to be tagged in order to know that all the SNPs in the region are associated with a trait. This enables researchers to more quickly sort through the millions of SNPs present in the human genome to find the ones most relevant to disease. The further identification and characterization of disease-associated SNPs can provide information on disease risk and facilitate the development of new drugs and techniques for diagnosis.
For the HapMap project, researchers initially attempted to identify one common SNP in every 5,000 bases of DNA from four distinct populations. The detection of SNPs was performed using different genotyping technologies capable of identifying the specific alleles carried by each person. In the first two stages of the project, Phases I and II, researchers investigated DNA from 270 individuals, including Japanese persons, Americans of European descent, members of the Han Chinese ethnic group, and members of the Yoruba people of Nigeria. Phase I, which was completed in 2005, resulted in the identification of roughly one million SNPs, and phase II, which was completed in 2007, produced data on more than 3.1 million SNPs. Later, as part of a follow-up effort known as HapMap 3, scientists published data on more than 1,000 new samples from 11 populations.
Because the project generated data on SNPs and haplotypes within distinct ethnic populations, it raised several important ethical concerns. For example, if ethnic groups were found to carry SNPs that place them at increased risk for certain types of disease, members of these groups could experience stigmatization and social or occupational discrimination. However, in improving the understanding of genetic variation within and between populations, the HapMap project has not only enriched scientific knowledge of disease but also enabled the development of population-based screening technologies that are fundamental for disease prevention. The data from the HapMap project was also used to investigate genetic variations underlying differences in response to environmental factors, including prescription drugs.